Literature DB >> 18522682

Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy.

Hideki Kawamura1, Toshiya Kamiyama, Takahito Nakagawa, Kazuaki Nakanishi, Hideki Yokoo, Munenori Tahara, Hirofumi Kamachi, Hirofumi Toi, Michiaki Matsushita, Satoru Todo.   

Abstract

BACKGROUND AND AIM: Conversion of data from technetium 99 m diethylenetriaminepentaacetic acid galactosyl human serum albumin (99mTc-GSA) scintigraphy to ICGR15 (indocyanin green retention at 15 min) is an easy and convenient method for obtaining parameters to determine the appropriate and safe extent of liver resection. We investigated a conversion method which also accounts for LHL15 (receptor index: uptake ratio of the liver to the liver plus heart at 15 min) and HH15 (blood clearance index: uptake ratio of the heart at 15 min to that at 3 min) characteristics.
METHODS: Cases included 282 patients undergoing hepatic resection following 99mTc-GSA scintigraphy and an ICG tolerance test. Degree of liver dysfunction was classified as A, B, or C according to criteria of the Liver Cancer Study Group of Japan.
RESULTS: HH15 demonstrated a larger distribution in patients with liver damage A, while LHL15 demonstrated a larger distribution in patients with liver damage B. In liver damage A, the conversion formula ICGR15 = 87.0-79.6 x LHL15 was obtained, and in liver damage B, the conversion formula ICGR15 = -23.3 + 72.4 x HH15 was obtained, and correlation with ICGR15 was higher (r = 0.61, P < 0.0001) than when the data were not segregated by liver damage severity. Furthermore, postoperative hyperbilirubinemia significantly occurred in cases where both ICGR15 and converted ICGR15 were high.
CONCLUSIONS: Conversion models based on data segregated by severity of liver damage were more closely correlated with ICGR15 than conversion models not based on segregated data. By using this converted ICGR15, preoperative estimation of hepatic functional reserve can become more reliable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522682     DOI: 10.1111/j.1440-1746.2008.05389.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  A Novel Noninvasive Method for Predicting Liver Fibrosis by Quantifying the Estrangement of Indocyanine Green Retention Rate and Tc-99m-diethylenetriamine-penta-acetic Acid-galactosyl Human Serum Albumin Scintigraphy.

Authors:  Takehiko Hanaki; E I Uchinaka; Takuki Yagyu; Masaki Morimoto; Joji Watanabe; Kozo Miyatani; Kyoichi Kihara; Tomoyuki Matsunaga; Manabu Yamamoto; Yoji Fukumoto; Naruo Tokuyasu; Shuichi Takano; Teruhisa Sakamoto; Soichiro Honjo; Toshimichi Hasegawa; Yoshiyuki Fujiwara
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.

Authors:  Noboru Harada; Ken Shirabe; Takashi Maeda; Hiroto Kayashima; Shintaro Takaki; Yoshihiko Maehara
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

3.  Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.

Authors:  Toru Beppu; Hidetoshi Nitta; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Morikatsu Yoshida; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

4.  Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.

Authors:  Junhao Zheng; Xu Feng; Yuelong Liang; Jingwei Cai; Zhaoqi Shi; Mubarak Ali Kirih; Liye Tao; Xiao Liang
Journal:  Surg Endosc       Date:  2020-07-06       Impact factor: 4.584

5.  Surgical treatment of hepatocellular carcinoma with severe intratumoral arterioportal shunt.

Authors:  Hiromichi Ishii; Teruhisa Sonoyama; Shingo Nakashima; Hiroyuki Nagata; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Toshiya Ochiai; Yukihito Kokuba; Chohei Sakakura; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

6.  Hepatectomy in a hepatocellular carcinoma case with Dubin-Johnson syndrome and indocyanine green excretory defect.

Authors:  Hideki Aoki; Toshiaki Morihiro; Takashi Arata; Nobuhiko Kanaya; Shou Takeda; Takayuki Ninomiya; Masayuki Seita; Kou Katsuda; Kohji Tanakaya; Hitoshi Takeuchi
Journal:  Clin J Gastroenterol       Date:  2012-12-06

7.  Significance of functional hepatic resection rate calculated using 3D CT/(99m)Tc-galactosyl human serum albumin single-photon emission computed tomography fusion imaging.

Authors:  Yosuke Tsuruga; Toshiya Kamiyama; Hirofumi Kamachi; Shingo Shimada; Kenji Wakayama; Tatsuya Orimo; Tatsuhiko Kakisaka; Hideki Yokoo; Akinobu Taketomi
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

8.  Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin.

Authors:  Tatsuyuki Tonan; Kiminori Fujimoto; Aliya Qayyum; Sanae Azuma; Masatoshi Ishibashi; Takato Ueno; Noriyuki Ono; Junji Akiyoshi; Sunao Matsushita; Naofumi Hayabuchi; Takumi Kawaguchi; Michio Sata
Journal:  Exp Ther Med       Date:  2011-04-11       Impact factor: 2.447

9.  Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy.

Authors:  Shingo Shimada; Toshiya Kamiyama; Tatsuya Orimo; Akihisa Nagatsu; Yoh Asahi; Yuzuru Sakamoto; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2020-06-10       Impact factor: 2.754

10.  Hepatectomy in a case of hepatocellular carcinoma with constitutional indocyanine green excretory defect.

Authors:  Richi Nakatake; Morihiko Ishizaki; Chika Miyasaka; Kosuke Matsui; Masaki Kaibori
Journal:  Int J Surg Case Rep       Date:  2018-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.